Final ruling in the EVACOL–CROCS litigation
The lawsuit began in 2016 when the U.S. brand registered the “three-dimensional mark” with the Colombian Superintendence of Industry, enabling it to sue the Colombian company for imitation of three models. In the first instance, in 2019, the local regulatory authority ruled in favor of CROCS, ordering the withdrawal of EVACOL products and the destruction of molds. Later, in 2024, the Bogotá Superior Court overturned the decision, and finally, in February 2025, the Constitutional Court declined to admit the case for review, exercising its autonomy, thus closing the dispute between the two brands. EVACOL is now considering the possibility of claiming compensation for damages caused.